Shingles in an 18-Year-Old: Understanding the Cause
Shingles on the back of an 18-year-old girl who had chickenpox as a child is caused by reactivation of the varicella-zoster virus (VZV) that has remained dormant in her dorsal root ganglia since her primary infection.
Mechanism of Disease
After the initial chickenpox infection in childhood, VZV does not leave the body. Instead, it establishes latency in the sensory nerve ganglia (dorsal root ganglia) along the spinal cord 1. The virus can remain dormant for years or decades before reactivating to cause herpes zoster (shingles). The thoracic dermatomes (back region) are the most common site for herpes zoster, accounting for 40-50% of all cases 1.
Why Reactivation Occurs in Young Adults
While shingles is classically associated with older adults, it can occur at any age after primary varicella infection 2, 3. The key trigger is declining VZV-specific cellular immunity 4. In an 18-year-old, several factors may precipitate reactivation:
Primary Risk Factors to Investigate:
Immunosuppression or immunodeficiency: This is the most critical factor to evaluate in a young patient with shingles 1
Stress and physiological triggers 6, 2:
- Acute viral or febrile illnesses
- Physical or emotional stress
- Ultraviolet light exposure 7
- Recent surgery or trauma
Medications: Corticosteroids or other immunosuppressive drugs 8
Clinical Presentation Confirmation
The diagnosis is primarily clinical 4. The back location fits the typical dermatomal distribution, with the rash beginning as erythematous macules, progressing to clear vesicles with pain (often preceding the rash by 24-72 hours), then pustulation and scabbing over 2-3 weeks 1.
Critical Next Steps
In any patient under 50 years with herpes zoster, immunocompromise must be actively excluded 1. This warrants:
- HIV testing
- Complete blood count
- Assessment for underlying malignancy or autoimmune disease
- Review of any medications or recent illnesses
Important Caveat:
While immunosuppression is the primary concern in young patients with shingles, approximately 15-20% of the general population will develop herpes zoster in their lifetime, and it can occur spontaneously in otherwise healthy young adults 1, 9. However, the clinical prudence dictates ruling out immunocompromise first.
Treatment Implications
Systemic antiviral therapy should be initiated within 72 hours of rash onset 4. For an 18-year-old with thoracic (back) involvement, antiviral therapy is indicated to shorten healing time, reduce pain, and prevent complications 4. Options include acyclovir, valacyclovir, or famciclovir 1, 3.
The evaluation should focus on identifying any underlying immunocompromising condition, as this would significantly impact both immediate management and long-term prognosis 1.